Gilead’s new commercials are for the HIV prevention drug it once said it didn’t see as a ‘commercial opportunity.’
Category: Forbes
Icahn Opposes Cigna-Express Scripts Deal, Citing Amazon And ‘Flawed’ PBM Rebates
Investor Carl Icahn went public Tuesday with his opposition to Cigna’s proposed purchase of Express Scripts, saying the health insurer is overpaying amid a challenging regulatory environment and the entrance of Amazon into the pharmacy business.
Bots Are Dominating Discussion About E-Cigarettes On Twitter
Researchers using data from Twitter to analyze trends in e-cigarette use in the U.S. found the conversation dominated by bot accounts, which appeared to favor positive messages.
Pentagon Bans GPS Fitness Apps, Says They’re ‘Significant Risk’ To Troops
After concerns were raised earlier this year, the Pentagon has banned military troops and other workers at sensitive sites from using fitness trackers and other applications that can reveal the user’s location.
The Single Most Important Skill You Need To Thrive At Work
No, it’s not Excel mastery or powerpoint domination. It’s resilience. The higher your resilience, the better you perform.
Two Mistakes Investors Make When Investing In Biotechnology Companies
Biotechnology stocks were some of the strongest performing stocks from 2009-2015. Then, the biotech bubble burst and just about every major biotech stock plunged into a private bear market.
Four Healthcare Startups Raised Over $130 Million Last Month
Fundraising among healthcare startups had the hottest July in the past decade, led by four companies that each raised over $130 million.
Rite Aid Shareholders’ Fear Of Amazon Key To Albertsons Vote
Rite Aid’s argument before shareholders that the Albertsons merger may be the only savior will be put to the test Thursday when shareholders vote on the deal.
Ovid Therapeutics Drug, Invented 41 Years Ago, May Help People With A Rare Disorder
This morning, Ovid Therapeutics, a small biotechnology company, is announcing data indicating that a drug, gaboxadol, may be of some help for patients with a condition called Angelman Syndrome.
Ovid Therapeutics Drug, Invented 41 Years Ago, May Help People With A Rare Disorder
This morning, Ovid Therapeutics, a small biotechnology company, is announcing data indicating that a drug, gaboxadol, may be of some help for patients with a condition called Angelman Syndrome.
